Amvuttra

Active Ingredient(s): Vutrisiran
FDA Approved: * June 13, 2022
Pharm Company: * ALNYLAM PHARMS INC
Category: Genetic Disorders
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Amvuttra 25 mg/.5ml Subcutaneous Injection
NDC: 71336-1003
Labeler:
Alnylam Pharmaceuticals, Inc.